Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance
1996

Apoptosis-Regulatory Genes in Lung Tumors

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): JG Reeve, J Xiong, J Morgan, NM Bleehen

Primary Institution: Medical Research Council Clinical Oncology and Radiotherapeutics Unit, Medical Research Council Centre, Cambridge, UK

Hypothesis

The study investigates the expression of bcl-2, bcl-x, and bax in lung tumor cell lines and their relationship to p53 expression and drug resistance.

Conclusion

The expression of apoptosis-regulatory genes bcl-2, bcl-x, and bax is significantly altered in lung tumor cell lines, which may influence their response to therapy.

Supporting Evidence

  • Bcl-2 was hyperexpressed in 15 of 16 small-cell lung cancer cell lines.
  • Bax gene transcripts were hyperexpressed in most SCLC and NSCLC cell lines.
  • Mutant p53 gene expression was detected in the majority of the cell lines.

Takeaway

This study looks at how certain genes that control cell death behave in lung cancer cells, which can help us understand why some cancer treatments work better than others.

Methodology

The study examined gene expression in lung cancer cell lines using Northern blot analysis and RT-PCR.

Limitations

The study primarily focuses on cell lines, which may not fully represent the complexity of lung tumors in patients.

Participant Demographics

Cell lines derived from untreated and treated patients with small-cell and non-small-cell lung cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication